GBS Inc. (NYSE:GBS – Get Rating)’s share price traded down 6.6% during mid-day trading on Thursday . The company traded as low as $0.39 and last traded at $0.39. 94,195 shares changed hands during mid-day trading, a decline of 91% from the average session volume of 1,071,527 shares. The stock had previously closed at $0.42.
GBS Stock Performance
The firm’s 50 day moving average is $0.64 and its two-hundred day moving average is $0.69. The stock has a market capitalization of $5.84 million, a PE ratio of -0.70 and a beta of 1.07.
GBS (NYSE:GBS – Get Rating) last announced its quarterly earnings data on Wednesday, August 31st. The company reported ($0.14) EPS for the quarter, beating analysts’ consensus estimates of ($0.18) by $0.04. On average, analysts anticipate that GBS Inc. will post -0.31 EPS for the current year.
Institutional Inflows and Outflows
GBS Inc operates as a biosensor diagnostic technology company. It offers Saliva Glucose Biosensor that uses saliva to measure glucose non-invasively. The company also focuses on developing COV2 test, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumour markers, hormones, and nucleic acid diagnostic modalities.
- Get a free copy of the StockNews.com research report on GBS (GBS)
- The Institutions Hold On To Darden Restaurants International
- What Steelcase’s Earnings Say About the Return to the Office?
- Is The Golden Age Of Homebuilding Already Over?
- These 3 Big Dividend Payers Also Boast Strong Price Growth
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
Receive News & Ratings for GBS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GBS and related companies with MarketBeat.com's FREE daily email newsletter.